The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin-The Sit2Mix trial

Creative Commons License

Linjawi S., Sothiratnam R., SARI R., Andersen H., Hiort L. C., Rao P.

PRIMARY CARE DIABETES, vol.9, no.5, pp.370-376, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.1016/j.pcd.2014.11.001
  • Journal Name: PRIMARY CARE DIABETES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.370-376
  • Keywords: Biphasic insulin, Sitagliptin, Type 2 diabetes, Randomized trial, COMBINATION, EFFICACY, SAFETY, GLARGINE, MELLITUS
  • Open Archive Collection: AVESIS Open Access Collection
  • Akdeniz University Affiliated: Yes

Abstract

Aims: Investigate efficacy and tolerability of intensifying diabetes treatment with onceor twice-daily biphasic insulin aspart 30 (BIAsp 30) added to sitagliptin, and twice-daily BIAsp 30 without sitagliptin in patients with type 2 diabetes (T2D) inadequately controlled on sitagliptin.